Can Vitamin D Reduce Total Mortality?

Can Vitamin D Reduce Total Mortality?2018-01-17T17:01:24-05:00

Strengths and Limitations of Current Epidemiologic Studies: Vitamin D as a Modifier of Colon and Prostate Cancer Risk

Strengths and Limitations of Current Epidemiologic Studies: Vitamin D as a Modifier of Colon and Prostate Cancer Risk2018-01-17T17:01:24-05:00

Epidemiology of prostate cancer

Epidemiology of prostate cancer2018-01-17T17:01:24-05:00

The epidemiology of vitamin D and cancer incidence and mortality: A review (United States)

The epidemiology of vitamin D and cancer incidence and mortality: A review (United States)2018-01-17T17:01:24-05:00

Multiple sclerosis and hepatitis B vaccination: Could minute contamination of the vaccine by partial Hepatitis B virus polymerase play a role through molecular mimicry?

Multiple sclerosis and hepatitis B vaccination: Could minute contamination of the vaccine by partial Hepatitis B virus polymerase play a role through molecular mimicry?2018-01-17T17:01:24-05:00

The epidemiology of vitamin D and colorectal cancer: recent findings

The epidemiology of vitamin D and colorectal cancer: recent findings2018-01-17T17:01:24-05:00

Epidemiology of Type I Diabetes mellitus in Switzerland: steep rise in incidence in under 5 year old children in the past decade

Epidemiology of Type I Diabetes mellitus in Switzerland: steep rise in incidence in under 5 year old children in the past decade2018-01-17T17:01:24-05:00

Vitamin D Status and Cancer Incidence and Mortality

Vitamin D Status and Cancer Incidence and Mortality2018-01-17T17:01:24-05:00

Dairy products, calcium and phosphorus intake, and the risk of prostate cancer: results of the French prospective SU.VI.MAX (Supple´mentation en Vitamines et Mine´raux Antioxydants) study

Dairy products, calcium and phosphorus intake, and the risk of prostate cancer: results of the French prospective SU.VI.MAX (Supple´mentation en Vitamines et Mine´raux Antioxydants) study2018-01-17T17:01:24-05:00

Most Patients With Multiple Sclerosis or a Clinically Isolated Demyelinating Syndrome Should Be Treated at the Time of Diagnosis

Most Patients With Multiple Sclerosis or a Clinically Isolated Demyelinating Syndrome Should Be Treated at the Time of Diagnosis2018-01-17T17:01:24-05:00